Ellington Credit Co — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ellington Credit Co filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($7.87M) | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | $6.59M | Jun 23, 2025 |
| FY2025 | Mar 31, 2024 | $3.96M | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | $4.56M | Jun 23, 2025 |
| FY2023 | Dec 31, 2022 | ($30.20M) | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | ($2.76M) | Mar 11, 2022 |
| FY2021 | Sep 30, 2021 | $860.0K | Mar 11, 2022 |
| FY2021 | Jun 30, 2021 | ($4.54M) | Mar 11, 2022 |
| FY2021 | Mar 31, 2021 | $127.0K | Mar 11, 2022 |
| FY2021 | Dec 31, 2020 | $7.39M | Mar 11, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $9.21M | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | $9.11M | Jun 23, 2025 |
| FY2025 | Mar 31, 2024 | ($1.21M) | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | ($10.02M) | Jun 23, 2025 |
| FY2023 | Dec 31, 2022 | $22.42M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $27.88M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $24.37M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $17.53M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $28.85M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $34.41M | Mar 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $783.56M | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | $824.09M | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | $945.69M | Jun 23, 2025 |
| FY2023 | Dec 31, 2022 | $1.05B | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $1.60B | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.19B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $1.49B | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.68B | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.89B | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $1.43B | Mar 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $555.06M | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | $630.37M | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | $809.45M | Jun 23, 2025 |
| FY2023 | Dec 31, 2022 | $941.22M | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | $1.44B | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.03B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $1.33B | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $1.52B | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.69B | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $1.29B | Mar 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $228.50M | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | $193.73M | Jun 23, 2025 |
| FY2025 | Mar 31, 2024 | $142.92M | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | $136.24M | Jun 23, 2025 |
| FY2025 | Dec 31, 2022 | $112.41M | Jun 23, 2025 |
| FY2023 | Dec 31, 2021 | $154.23M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $166.40M | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $160.84M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $153.82M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $192.70M | Mar 12, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($171.74M) | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | ($155.16M) | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | ($138.65M) | Jun 23, 2025 |
| FY2023 | Dec 31, 2022 | ($128.67M) | Mar 12, 2024 |
| FY2022 | Dec 31, 2021 | ($84.77M) | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | ($63.34M) | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | ($69.64M) | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | ($77.19M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($47.49M) | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | ($39.41M) | Mar 14, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $17.38M | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | $31.84M | Jun 23, 2025 |
| FY2025 | Mar 31, 2024 | $22.44M | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | $38.53M | Jun 23, 2025 |
| FY2025 | Dec 31, 2022 | $34.82M | Jun 23, 2025 |
| FY2023 | Dec 31, 2021 | $69.03M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | $58.17M | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | $35.35M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $18.59M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $56.12M | Mar 12, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | 0 | Jun 23, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | 0 | Jun 23, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 12, 2024 |
| FY2021 | Dec 31, 2021 | 0 | Mar 11, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Mar 11, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Mar 11, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Mar 11, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 11, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 37.56M | Jun 23, 2025 |
| FY2025 | Dec 31, 2024 | 29.65M | Jun 23, 2025 |
| FY2025 | Mar 31, 2024 | 19.82M | Jun 23, 2025 |
| FY2025 | Dec 31, 2023 | 18.60M | Jun 23, 2025 |
| FY2025 | Dec 31, 2022 | 13.38M | Jun 23, 2025 |
| FY2023 | Dec 31, 2021 | 13.11M | Mar 12, 2024 |
| FY2022 | Dec 31, 2020 | 12.34M | Mar 10, 2023 |
| FY2021 | Dec 31, 2019 | 12.46M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | 12.51M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | 13.34M | Mar 12, 2020 |